| Arielle S Silver, MD | |
|
2301 E. Evesham Road, Bldg 800, Suite 115, Voorhees, NJ 08043 | |
| (856) 424-5005 | |
| (856) 424-4716 |
| Full Name | Arielle S Silver |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 23 Years |
| Location | 2301 E. Evesham Road, Voorhees, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083623763 | NPI | - | NPPES |
| 25MA08135200 | Other | NJ | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 25MA08135200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Virtua Our Lady Of Lourdes Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trabecular Medical Group, Llc | 2365842440 | 18 |
News Archive
"California Rep. Howard Berman, the top Democrat on the Foreign Affairs Committee, unveiled a 923-page bill on Wednesday that would replace the Foreign Assistance Act of 1961 with a framework for providing developmental and economic U.S. aid," the Associated Press/Huffington Post reports, noting, "Berman's Global Partnerships Act of 2012 would change the aid system to focus on mutually agreed goals instead of the emphasis on donor-recipient ties, increase accountability and oversight, and eliminate duplication."
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis.
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff from the United States Food and Drug Administration (FDA).
Many people rely on continuous positive airway pressure (CPAP) machines as a safe and effective treatment for sleep apnea. But a new case report describes a rare complication—a lingering inflammatory disease of the lungs, apparently related to the use of contaminated well water in a CPAP machine. The report appears in the December Southern Medical Journal, official journal of the Southern Medical Association.
› Verified 8 days ago
| Entity Name | Arthritis & Rheumatic Disease Assoc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841238524 PECOS PAC ID: 6901886365 Enrollment ID: O20040726000066 |
News Archive
"California Rep. Howard Berman, the top Democrat on the Foreign Affairs Committee, unveiled a 923-page bill on Wednesday that would replace the Foreign Assistance Act of 1961 with a framework for providing developmental and economic U.S. aid," the Associated Press/Huffington Post reports, noting, "Berman's Global Partnerships Act of 2012 would change the aid system to focus on mutually agreed goals instead of the emphasis on donor-recipient ties, increase accountability and oversight, and eliminate duplication."
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis.
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff from the United States Food and Drug Administration (FDA).
Many people rely on continuous positive airway pressure (CPAP) machines as a safe and effective treatment for sleep apnea. But a new case report describes a rare complication—a lingering inflammatory disease of the lungs, apparently related to the use of contaminated well water in a CPAP machine. The report appears in the December Southern Medical Journal, official journal of the Southern Medical Association.
› Verified 8 days ago
| Entity Name | Trabecular Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427622661 PECOS PAC ID: 2365842440 Enrollment ID: O20210610002078 |
News Archive
"California Rep. Howard Berman, the top Democrat on the Foreign Affairs Committee, unveiled a 923-page bill on Wednesday that would replace the Foreign Assistance Act of 1961 with a framework for providing developmental and economic U.S. aid," the Associated Press/Huffington Post reports, noting, "Berman's Global Partnerships Act of 2012 would change the aid system to focus on mutually agreed goals instead of the emphasis on donor-recipient ties, increase accountability and oversight, and eliminate duplication."
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis.
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff from the United States Food and Drug Administration (FDA).
Many people rely on continuous positive airway pressure (CPAP) machines as a safe and effective treatment for sleep apnea. But a new case report describes a rare complication—a lingering inflammatory disease of the lungs, apparently related to the use of contaminated well water in a CPAP machine. The report appears in the December Southern Medical Journal, official journal of the Southern Medical Association.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arielle S Silver, MD 2301 E. Evesham Road, Bldg 800, Suite 115, Voorhees, NJ 08043-4509 Ph: (856) 424-5005 | Arielle S Silver, MD 2301 E. Evesham Road, Bldg 800, Suite 115, Voorhees, NJ 08043 Ph: (856) 424-5005 |
News Archive
"California Rep. Howard Berman, the top Democrat on the Foreign Affairs Committee, unveiled a 923-page bill on Wednesday that would replace the Foreign Assistance Act of 1961 with a framework for providing developmental and economic U.S. aid," the Associated Press/Huffington Post reports, noting, "Berman's Global Partnerships Act of 2012 would change the aid system to focus on mutually agreed goals instead of the emphasis on donor-recipient ties, increase accountability and oversight, and eliminate duplication."
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis.
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff from the United States Food and Drug Administration (FDA).
Many people rely on continuous positive airway pressure (CPAP) machines as a safe and effective treatment for sleep apnea. But a new case report describes a rare complication—a lingering inflammatory disease of the lungs, apparently related to the use of contaminated well water in a CPAP machine. The report appears in the December Southern Medical Journal, official journal of the Southern Medical Association.
› Verified 8 days ago
Kumar Rajagopalan, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 900 Centennial Blvd Ste M, Voorhees, NJ 08043 Phone: 856-325-6750 Fax: 856-325-6777 | |
Amy M Evangelisto, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2301 E. Evesham Road, Bldg 800, Suite 115, Voorhees, NJ 08043 Phone: 856-424-5005 Fax: 856-424-4716 | |
Stephen M Akers, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 900 Centennial Blvd, Suite K, Voorhees, NJ 08043 Phone: 856-325-6789 | |
Jason Palermo, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2309 E Evesham Rd, Suites 201 & 202, Voorhees, NJ 08043 Phone: 856-325-5400 Fax: 856-325-5416 | |
Dr. Robert Charles Baker, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 75 Wynnewood Dr, Voorhees, NJ 08043 Phone: 609-352-2012 Fax: 856-489-1420 | |
Dr. Eduardo Francisco Enriquez, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3 Brendenwood Dr, Voorhees, NJ 08043 Phone: 856-874-0202 Fax: 856-874-0220 |